title: Progression-free survival ratio as end point for phase II trials in advanced solid tumors.
authors.forename: Marc
authors.initials: M
authors.lastname: Buyse
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Quinaux
authors.forename: Alain
authors.initials: A
authors.lastname: Hendlisz
authors.forename: Vassilis
authors.initials: V
authors.lastname: Golfinopoulos
authors.forename: Christophe
authors.initials: C
authors.lastname: Tournigand
authors.forename: Rosemarie
authors.initials: R
authors.lastname: Mick
mesh_terms: D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D018572:Disease-Free Survival; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology